Clinical evaluation of dental and periodontal status in a group of oncological patients before chemotherapy by López Galindo, Mónica Paula et al.
E17
Med Oral Patol Oral Cir Bucal 2006;11:E17-21.                               Dental and periodontal status in a group of oncological patients                Oral Medicine and Pathology                                                                   Dental and periodontal status in a group of oncological patients
Clinical evaluation of dental and periodontal status in a group of 
oncological patients before chemotherapy
Mónica Paula López Galindo 1, José V. Bagán 2, Yolanda Jiménez Soriano 3, Francisco Alpiste 4, Carlos Camps 5
 
(1) Dentist. University of Valencia.
(2) Chairman of Oral Medicine, Valencia University Medical and Dental School. Head of the Service of Odontology, Valencia University 
General Hospital.
(3) Associate Professor of Oral Medicine, Valencia University Medical and Dental School.Valencia 
(4) Associate Professor of Periodontology, Valencia University.
(5) Head of the Service of Oncology, Valencia University General Hospital. (Spain)
Correspondence:
Dr. José Vicente Bagán Sebastián
Hospital General Universitario de Valencia
Servicio de Estomatología
Av/ Tres Cruces s/n
46.014 Valencia
E-mail: bagan@uv.es
Received: 25-01-2005   
Accepted: 4-12-2005
López-Galindo MP, Bagán JV, Jiménez-Soriano Y, Alpiste F, Camps C. 
Clinical evaluation of dental and periodontal status in a group of oncologi-
cal patients before chemotherapy. Med Oral Patol Oral Cir Bucal 2006;11:
E17-21.
© Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698- 6946
ABSTRACT
Objective: To evaluate the dental status of 88 cancer patients before chemotherapy.
Material and methods: Eighty-eight patients with cancer in different body locations were studied and compared with a control 
group. Dental plaque was assessed by means of the Silness and Löe index, dental status with the DMFT index, and periodontal 
status with the modified CPI index.
Results: In the oncological patients the mean Silness and Löe index was 1.28±0.11. Patients showed multiple missing teeth (mean 
number 7.55±0.80); the mean number of decayed teeth was 2.10±0.36; and the mean number of filled teeth was 2.27±0.37. 
As to periodontal status, the mean modified CPI index was 1.45±0.11.
In the control group, the mean Silness and Löe index was 0.94±0.00. The mean number of decayed teeth was 1.21±0.25; the 
mean number of missing teeth was 4.97±0.67; and the mean number of filled teeth was 4.82±0.44. The mean modified CPI 
index was 1.29±0.10.
Conclusions: Oncological patients in our study showed more dental plaque versus healthy patients and more decayed and 
missing teeth. However, patients in the control group showed more filled teeth than cancer patients. Periodontal status as de-
termined by the modified CPI index was similar in both patient groups.
Key words: Chemotherapy, dental and periodontal status.
RESUMEN
Objetivos: Valorar el estado bucodental en 88 pacientes con cánceres corporales, previo al inicio de su tratamiento quimioterápico.
Diseño del estudio: Estudiamos 88 pacientes con cánceres de diferentes localizaciones corporales y los comparamos con un 
grupo control. Analizamos la placa dental (mediante el índice de Silness y Löe), el estado dental (mediante el índice CAO.D) 
y el estado periodontal (índice CPI modificado). 
Resultados: En el grupo de pacientes oncológicos, la media del índice de placa de Silnness y Löe fue de 1,28±0,11. Los 
pacientes presentaban múltiples ausencias dentarias, siendo la media de dientes ausentes por caries de 7,55±0,80. También 
se observó que la media de caries por paciente era de 2,10±0,36 y de dientes obturados de 2,27±0,37; por lo que respecta al 
estado periodontal, el valor del índice CPI modificado fue de 1,45±0,11.
 En el grupo control, la media del índice de placa de Silnness y Löe fue de 0,94±0,00. Por lo que respecta a los dientes caria-
dos, la media era de 1,21±0,25; la media de dientes ausentes por caries era de 4,97±0,67 y el valor de la media de los dientes 
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INTRODUCTION
Antineoplastic therapy includes surgery, radiotherapy and che-
motherapy alone or in combination, depending on the nature 
and extent of the tumor (1).
Antineoplastic chemotherapy presently consists of the use of 
drugs (cytostatic agents) that destroy or hinder the proliferation 
of tumor cells. Treatment is followed by tumor cell necrosis, 
after which a neoplastic cell recovery phase may be observed. 
The problem of these treatments is that in most cases their ac-
tion is not selectively target to tumor cells. In effect, anticancer 
drugs affect not only neoplastic cells but also other similarly 
rapidly dividing normal cells such as bone marrow, hair folli-
cle cells and the orodigestive epithelium (2). Chemotherapy 
is characterized by a narrow borderline between its antitumor 
effects and toxicity (which may even prove fatal) (3). Due to 
the side effects upon the oral cavity, patient oral status prior 
to chemotherapy is important for the quality of life of these 
patients, because the possibilities for intervention after che-
motherapy are limited.
The present study explores oral and dental status in a group of 
patients with cancer before chemotherapy, with the evaluation 
of possible prior dental intervention, taking into account aspects 
such as tumor stage and location, and patient dental hygiene 
and motivation.
MATERIAL AND METHODS
Oral and dental status was explored in 88 patients in the Service 
of Odontology (Valencia University General Hospital; Valencia, 
Spain), between October 2000 and January 2004.
Inclusion criteria were:
1. A diagnosis of cancer in any location, except oral cancer.
2. Patients programmed for systemic chemotherapy.
3. Presence of teeth to allow the evaluation of dental and 
periodontal status. Edentulous patients were excluded from 
the study.
The mean patient age was 56.75 years (standard deviation (SD) 
= 14.16 years). There were 38 males (43.2%) and 50 females 
(56.8%). The patients were examined in the mentioned Ser-
vice of Odontology prior to chemotherapy. A clinical history 
was compiled, and certain data were recorded, such as: toxic 
habits (smoking, alcohol abuse) and tumor diagnosis, location 
and stage. Depending on their oral hygiene status, the patients 
were classified into three groups: excellent oral hygiene (tooth 
brushing 3 times a day); good oral hygiene (brushing 1-2 times 
a day); poor oral hygiene (failure to brush daily).
To conduct a comparative study versus healthy individuals, 
90 controls were included, based on the following inclusion 
criteria: absence of systemic disorders; absence of medication 
of any kind at the time of the study.
There were no significant differences between the two groups 
in terms of age and sex. Mean age in the control group was 
55.51 years (SD = 15.18). There were 41 males (45.6%) and 
49 females (54.4%).
After compiling the clinical history, the following explorations 
were performed in both groups:
(a) Evaluation of dental plaque. Buccal and lingual/palatal 
examination of the dental arches was performed with a plane 
mouth mirror (number 5) and a dental probe (number 23). 
Dental plaque was assessed in the following teeth: 1.6, 1.1, 
2.4, 3.6, 3.1 and 4.6, according to the Silness and Löe scale 
(4). After the teeth were examined, the arithmetic mean was 
calculated for all scores obtained in each patient.
(b) Evaluation of the DMFT index (4). Using a plane mouth mi-
rror (number 5) and a dental probe (number 23), we recorded the 
number of decayed (D), missing (M) and filled (F) permanent 
teeth. The sum of these three values yielded the corresponding 
DMFT index (T = permanent teeth). The caries criteria used 
were those of the World Health Organization (WHO), which 
defines caries when “... a lesion in a pit or fissure, or on a 
smooth tooth surface, has an unmistakable cavity, undetermined 
enamel, or a detectably softened floor or wall” (5). A crown 
was considered filled, with decay, when it had one or more 
permanent restorations and one or more areas that were seen to 
be decayed. Third molars were excluded from the study.
(c) Evaluation of the modified Community Periodontal Index 
(modified CPI)(4,6-8). Instead of dividing the mouth into 
sextants, we took the following tooth numbers: 1.7 or 1.6, 1.1, 
2.6 or 2.7, 3.6 or 3.7, 3.1 and 4.6 or 4.7. Periodontal probing 
was carried out with a plane mouth mirror (number 5) and 
a dental probe. Each tooth was examined in the buccal and 
lingual/palatal surfaces at three points (mesial, medial and 
distal); the greatest probe depth was registered in mm. The 
mean value of the pocket depth was obtained by calculating the 
arithmetic mean of the greatest values obtained in the explored 
teeth. Periodontal status was scored as follows: 0 = health; 1 = 
bleeding; 2 = supra- or subgingival calculus, excessive fillings; 
3 = pocket depth 4-5 mm; 4 = pocket depth 6 mm or more; X 
= excluded sextant.
The data obtained were subjected to descriptive and com-
parative statistical analysis. The Student t-test was used for 
comparing the means of quantitative variables, while analysis 
of variance (ANOVA) was performed to compare the means 
of more than two groups of quantitative variables. Statistical 
significance was considered for p ≤ 0.05.
obturados era de 4,82±0,44. La media del índice periodontal CPI modificado, en el grupo control, fue de 1,29±0,10.
Conclusiones: Los pacientes oncológicos de nuestro estudio presentaron mayor cantidad de placa dental que los pacientes 
sanos. Además tenían más dientes cariados y ausentes que los individuos sanos. En cambio, los pacientes del grupo control 
presentaron más dientes obturados que los pacientes afectos de cáncer. El estado periodontal estudiado en ambos grupos de 
pacientes, mediante el índice CPI modificado, demostró que era similar en los individuos sanos y en los oncológicos. 
Palabras clave: Quimioterapia, estado dental y periodontal. 
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RESULTS
Thirty-six patients (40.9%) were diagnosed with adenocarci-
noma, 22 (25.0%) with infiltrating ductal carcinoma, 8 (9.1%) 
squamous cell carcinoma, and 22 patients (25.0%) with some 
other type of cancer (Table 1). 
The distribution of tumor location was as follows: 27 patients 
(30.7%) had intestinal cancer, 26 (29.5%) had breast cancer, 
12 patients (13.6%) had lung cancer, and 23 (26.1%) presented 
multiple locations (Table 2). 
Tumor staging according to the TNM classification showed 
13 patients (14.8%) to be in stage I, 19 (21.6%) in stage II, 22 
(25.0%) in stage III, and 34 (38.6%) in stage IV. The data rela-
ting to oral hygiene on both groups are reported in Table 3.
The results relating to dental and periodontal evaluation (inclu-
ding plaque index, mean carious decayed and filled teeth, DMFT 
index and modified CPI index) are described in Table 4.
Table 1. Number and percentage of patients, according to tumor diagnosis in 
the oncological group.
Table 2. Number and percentage of patients, according to tumor location 
in the oncological group.
Diagnosis No. of cases % 




Squamous cell carcinoma 8 9.1 
Others 22 25.0 
Tumor location No. of cases % 
Intestine 27 30.7 
Breast 26 29.5 
Lung 12 13.6 
Others 23 26.1 
Oral hygiene 
Oncological
patients (n, %) Controls (n, %) 
Excellent 8 (9.1 %) 16 (17.8 %) 
Good 60 (68.2 %) 71 (78.9 %) 
Poor 20 (22.7 %) 3 (3.3 %) 
Oncological patients  
(n = 88) 
(mean�SD)
Controls (n = 90) 
(mean�SD)
Significance




Carious teeth 2.06�3.36 1.21�2.37 t=1.95
p=0.05
Decayed teeth 7.55�7.52 4.97�6.34 t=2.48
p=0.01
Filled teeth 2.27�3.48 4.82�4.22 t=-4.39
p=0.00
DMFT index 11.89�8.26 10.97�6.74 t=0.81
p=0.42
Modified CPI index 1.45�1.04 1.29�0.98 t=1.08
p=0.28
Table 3. Oral hygiene in both groups of patients (oncological and control), 
with corresponding statistical significance.
Table 4. Mean, standard deviation and statistical significance in both groups of patients.
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DISCUSSION
While chemotherapy offers important positive results in the 
management of cancer, it also has a series of undesirable effects. 
In this context, the creation of healthy oral conditions before 
chemotherapy is administered can afford patient benefits, since 
the negative effects of chemotherapy upon the oral cavity are 
less pronounced in the presence of a healthy mouth without 
dental or periodontal disorders (4,9-12).
To assess oral hygiene, the Silness and Löe index was measured 
– yielding a mean score of 1.28±0.11 in the 88 oncological 
patients, and 0.94±0.00 in the control group. The only study 
similar to our own found in the literature was published by 
Jankovic et al. (13). In this study, 20 healthy patients were com-
pared with 30 oncological patients before the administration 
of chemotherapy; in both groups the age and sex distributions 
were similar to our own. Based on the Silness and Löe index, 
the authors recorded a value of 1.39±0.65 in the 20 healthy 
subjects and 1.57±0.90 in the 30 oncological patients. The 
study failed to mention whether the intergroup differences were 
statistically significant, however. The values recorded in both 
groups were slightly greater than our own.
Our study reflects a high DMFT index in the oncological group, 
with a mean value of 11.89±0.88. The magnitude of this score 
was not due to the decayed (mean 2.10±0.36) or filled teeth 
(mean 2.27±0.37), but to the missing teeth (mean 7.55±0.80). 
The mean DMFT score for the control group was 10.97±0.71, 
and was largely attributable to missing and filled teeth.
In a study of 736 healthy adults aged between 19-64 years, 
Athanassouli et al (14) in 1990 reported a DMFT index of 
8.99±5.98 for the 19-24 years age interval, versus 17.05±6.58 
for the 55-64 years interval. These values are slightly greater 
than our own.
As regards periodontal status assessed by the modified CPI 
index, the mean value was found to be higher among the on-
cological patients (mean 1.45±0.11) than in the healthy group 
(mean 1.29±0.10) – though the difference failed to reach sta-
tistical significance (t=1.08; p=0.28).
Diamanti-Kipioti et al. (15), in 169 healthy Athenian farmers 
aged 25-64 years, found the CPITN (Community Periodontal 
Index of Treatment Needs) to be 1±1.4 (i.e., similar to the score 
recorded in our groups of patients).
On relating different parameters to periodontal status, statistica-
lly significant correlations were observed. In effect, a positive 
relation was found between the Silness and Löe plaque index 
and the modified CPI periodontal index (R=0.55; p=0.00), i.e., 
the higher the plaque index, the higher the periodontal index. 
The presence of dental plaque is related to poorer periodontal 
status (16,17).
A positive relationship was found between carious teeth and 
the modified CPI index (R=0.24; p=0.03).
Patients initially presenting a poor periodontal and/or carious 
status who are treated before chemotherapy and receive in-
tense oral care during treatment show a significant reduction 
in the frequency of the oral complications associated with 
chemotherapy (18-20). Many authors consider it necessary to 
provide dental treatment before chemotherapy, eliminating any 
possible foci of dental disease with the aim of minimizing or 
eradicating the effects of chemotherapy upon the oral cavity 
(21-33). Moderate dental plaque levels may contribute to local 
infection in immunocompromised patients (18).
Trauma-inducing prostheses, and sharp-edged or broken teeth 
imply an increased risk of ulcerations and mucositis (34). Hence 
the importance of correcting these possible alterations before 
chemotherapy is administered.
In conclusion, our oncological patients showed more dental 
plaque, and more decayed and missing teeth than the controls. 
However, no differences in modified CPI periodontal index 
were observed between the two groups.
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